Free Trial

ZimVie (ZIMV) Stock Price, News & Analysis

ZimVie logo
$14.15 -0.18 (-1.26%)
As of 01/22/2025 04:00 PM Eastern

About ZimVie Stock (NASDAQ:ZIMV)

Key Stats

Today's Range
$14.15
$14.40
50-Day Range
$13.17
$14.86
52-Week Range
$13.01
$22.40
Volume
88,668 shs
Average Volume
93,644 shs
Market Capitalization
$390.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.50
Consensus Rating
Hold

Company Overview

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

ZimVie Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
55th Percentile Overall Score

ZIMV MarketRank™: 

ZimVie scored higher than 55% of companies evaluated by MarketBeat, and ranked 507th out of 935 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    ZimVie has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    ZimVie has received no research coverage in the past 90 days.

  • Read more about ZimVie's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ZimVie is -1.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ZimVie is -1.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    ZimVie has a P/B Ratio of 0.92. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about ZimVie's valuation and earnings.
  • Percentage of Shares Shorted

    1.24% of the float of ZimVie has been sold short.
  • Short Interest Ratio / Days to Cover

    ZimVie has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ZimVie has recently decreased by 0.62%, indicating that investor sentiment is improving.
  • Dividend Yield

    ZimVie does not currently pay a dividend.

  • Dividend Growth

    ZimVie does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.24% of the float of ZimVie has been sold short.
  • Short Interest Ratio / Days to Cover

    ZimVie has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ZimVie has recently decreased by 0.62%, indicating that investor sentiment is improving.
  • News Sentiment

    ZimVie has a news sentiment score of 1.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.64 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for ZimVie this week, compared to 2 articles on an average week.
  • Search Interest

    Only 1 people have searched for ZIMV on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added ZimVie to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, ZimVie insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.02% of the stock of ZimVie is held by insiders.

  • Percentage Held by Institutions

    95.63% of the stock of ZimVie is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about ZimVie's insider trading history.
Receive ZIMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZimVie and its competitors with MarketBeat's FREE daily newsletter.

ZIMV Stock News Headlines

ZimVie Inc (ZIMV) Gets a Sell from Barclays
ZimVie Reports Third Quarter 2024 Financial Results
Mode Mobile is poised for massive growth and looking to disrupt the $1T+ smartphone industry - Invest Today
While other cell phone carriers are always looking for ways to squeeze every last penny out of their customers, my company pays users for the 40 hours a week they are using smartphone apps, listening to music, and watching videos online with their phones. And you can join us for just $0.26 per share. Plus, when you invest now, you can get up to 100% bonus shares!
ZimVie Inc. (ZIMV) Q3 2024 Earnings Call Transcript
ZimVie Inc. Reports Improved Q3 Financial Performance
See More Headlines

ZIMV Stock Analysis - Frequently Asked Questions

ZimVie's stock was trading at $13.95 at the beginning of 2025. Since then, ZIMV stock has increased by 1.4% and is now trading at $14.15.
View the best growth stocks for 2025 here
.

ZimVie Inc. (NASDAQ:ZIMV) posted its quarterly earnings results on Wednesday, October, 30th. The company reported $0.12 earnings per share (EPS) for the quarter. The company had revenue of $103.22 million for the quarter. ZimVie had a positive trailing twelve-month return on equity of 2.90% and a negative net margin of 77.31%.

Top institutional shareholders of ZimVie include Monarch Capital Management Inc. (0.24%) and SG Americas Securities LLC (0.04%). Insiders that own company stock include Camber Capital Management Lp, Vafa Jamali and Richard Heppenstall.
View institutional ownership trends
.

Shares of ZIMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ZimVie investors own include Chevron (CVX), Comcast (CMCSA), Bristol-Myers Squibb (BMY), McKesson (MCK), Charles Schwab (SCHW), Edwards Lifesciences (EW) and Yum! Brands (YUM).

Company Calendar

Last Earnings
10/30/2024
Today
1/22/2025
Next Earnings (Estimated)
2/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Dental equipment & supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:ZIMV
Fax
N/A
Employees
2,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$19.50
High Stock Price Target
$23.00
Low Stock Price Target
$16.00
Potential Upside/Downside
+37.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-393,280,000.00
Pretax Margin
-8.39%

Debt

Sales & Book Value

Annual Sales
$457.43 million
Cash Flow
$4.76 per share
Book Value
$15.43 per share

Miscellaneous

Free Float
26,214,000
Market Cap
$390.54 million
Optionable
Optionable
Beta
2.11
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (NASDAQ:ZIMV) was last updated on 1/23/2025 by MarketBeat.com Staff
From Our Partners